Medicare Enrolled
Dr. Mykola Alyskewycz, MD
Urology Physician · Glen Cove, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alyskewycz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alyskewycz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alyskewycz
Dr. Mykola Alyskewycz is an urology physician in Glen Cove, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alyskewycz performed 6,045 Medicare services across 2,468 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alyskewycz received a total of $5,464 from 41 pharmaceutical and/or device companies across 260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alyskewycz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in NY
$5,464 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,045
Medicare services
Top 15% in NY for urology physician
2,468
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~302 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,196 | $2 | $7 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
907 | $4 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
593 | $113 | $434 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
409 | $10 | $48 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
376 | $78 | $306 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
296 | $8 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
193 | $8 | $9 |
| PSA test (prostate cancer screening) | 153 | $18 | $55 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
140 | $8 | $26 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
87 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
87 | $8 | $24 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
81 | $233 | $977 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
59 | $94 | $392 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $136 | $574 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
50 | $86 | $412 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
50 | $8 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $73 | $266 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
40 | $41 | $193 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
37 | $79 | $292 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $122 | $442 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
27 | $77 | $331 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
25 | $18 | $55 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
25 | $33 | $115 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
23 | $5 | $14 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
21 | $47 | $169 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
19 | $25 | $77 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $123 | $464 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,464
Total received (2018-2024)
Avg $781/year across 7 years
Top 29% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
260
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,452 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,221
2023
$1,036
2022
$827
2021
$520
2020
$416
2019
$759
2018
$685
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$184
Astellas Pharma US Inc
$181
Boston Scientific Corporation
$151
Bayer Healthcare Pharmaceuticals Inc.
$120
Janssen Biotech, Inc.
$117
Antares Pharma, Inc.
$115
Tolmar, Inc.
$68
Endo USA, Inc.
$45
Teleflex LLC
$44
Verity Pharmaceuticals Inc.
$32
Dendreon Pharmaceuticals LLC
$28
DENTSPLY IH AB
$25
COLOPLAST CORP
$21
PFIZER INC.
$20
Ferring Pharmaceuticals Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Laborie Medical Technologies Corp.
$18
UROGEN PHARMA, INC.
$14
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$868
Janssen Biotech, Inc.
$634
TOLMAR Pharmaceuticals, Inc.
$333
Sumitomo Pharma America, Inc.
$326
Bayer Healthcare Pharmaceuticals Inc.
$303
PFIZER INC.
$289
Dendreon Pharmaceuticals LLC
$282
Myovant Sciences Inc.
$261
Endo Pharmaceuticals Inc.
$198
Bayer HealthCare Pharmaceuticals Inc.
$164
Boston Scientific Corporation
$151
Ferring Pharmaceuticals Inc.
$146
Medtronic USA, Inc.
$144
Antares Pharma, Inc.
$140
Tolmar, Inc.
$135
NeoTract Inc.
$130
Amgen Inc.
$112
Verity Pharmaceuticals Inc.
$80
Myriad Genetic Laboratories, Inc.
$78
Teleflex LLC
$74
UROVANT SCIENCES INC
$72
Coloplast Corp
$72
MEDIVATION FIELD SOLUTIONS LLC
$60
Endo USA, Inc.
$45
Avadel Specialty Pharmaceuticals, LLC
$40
Progenics Pharmaceuticals, Inc.
$33
UroGen Pharma, Inc.
$27
AbbVie Inc.
$27
Merck Sharp & Dohme LLC
$25
DENTSPLY IH AB
$25
AbbVie, Inc.
$24
Clarus Therapeutics Inc.
$22
COLOPLAST CORP
$21
ACCORD HEALTHCARE, INC.
$18
Laborie Medical Technologies Corp.
$18
SRS Medical Systems, Inc.
$16
Acerus Pharmaceuticals Corporation
$15
DENTSPLY IH Inc.
$14
UROGEN PHARMA, INC.
$14
Allergan Inc.
$13
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 33.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AVEED · BOTOX · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · INTERSTIM · JATENZO · JELMYTO · KANJINTI · KEYTRUDA · LOFRIC · LoFric · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · Rezum Generator · SpeediCath · Tlando · Trelstar · UROLIFT · UroCuff · UroLift · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
653
Per 100K population
47.0
County median income
$143,408
Nearest hospital
NORTHWELL HOSPITAL GLEN COVE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alyskewycz is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alyskewycz experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Alyskewycz performed 2,196 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alyskewycz receive payments from pharmaceutical companies?
Yes. Dr. Alyskewycz received a total of $5,464 from 41 companies across 260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alyskewycz's costs compare to other urology physicians in Glen Cove?
Dr. Alyskewycz's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alyskewycz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Glen Cove
Browse urology physicians in Glen Cove ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
TOLMAR Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from TOLMAR Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology